Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $44.6 million.

  • MDxHealth's Cash from Financing Activities fell 105.01% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.6 million, marking a year-over-year increase of 0.30%. This contributed to the annual value of $44.6 million for FY2024, which is 38.16% up from last year.
  • Latest data reveals that MDxHealth reported Cash from Financing Activities of $44.6 million as of FY2024, which was up 38.16% from $32.3 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Cash from Financing Activities registered a high of $66.5 million during FY2021, and its lowest value of $14.3 million during FY2020.
  • Its 3-year average for Cash from Financing Activities is $32.5 million, with a median of $32.3 million in 2023.
  • Per our database at Business Quant, MDxHealth's Cash from Financing Activities skyrocketed by 365.35% in 2021 and then tumbled by 68.85% in 2022.
  • MRY analysis of 5 years shows MDxHealth's Cash from Financing Activities stood at $14.3 million in 2020, then skyrocketed by 365.35% to $66.5 million in 2021, then tumbled by 68.85% to $20.7 million in 2022, then skyrocketed by 55.82% to $32.3 million in 2023, then surged by 38.16% to $44.6 million in 2024.
  • Its Cash from Financing Activities was $44.6 million in FY2024, compared to $32.3 million in FY2023 and $20.7 million in FY2022.